Brieflands

History

The company was first founded by Seyyed M. Miri and Seyed-M Alavian as an editorial group in a Medical Institute in 2007 to publish its medical journal. After three years of experience, the number of journals increased to 5 journals, and the company launched its first form of business as a VOF (collaboration) professional STM company in Heerlen, the Netherlands, which was called "Kowsarmedical Publishing." Respecting the publishing services (from submission to publishing), especially an in-house "Journal Management System," our journals increased to more than 60 STM journals between 2010 and 2019. Since 2022, "Brieflands" is the new brand name that acts as a "Science, Technical, Medical Publisher" that publishes more than 50 journals with the services provided by 97 expert employees in three different branches.


Business Profile

  • Brieflands is a Registered Trademark with record number 1454012.
  • Brieflands has been registered as a General partnership (Vennootschap onder firma) company in the Chamber of Commerce (Kamer van Koophandel) of the Netherlands since 2010.
  • Nedmedica is our related company which is specialized in Author Services. 
  • Our former branding name was Kowsarmedical Publishing (2010-2021).

Recent Submissions

  • Item type:Item,
    Arginine and Linear Growth in Children and Adolescents: Scientific Evidence or Marketing Claim?
    (Brieflands, 2026-11-30)
    Babak Elyasi
    ;
    Babak Elyasi [0009-0008-3308-8949]
    Context: Arginine is a conditionally essential amino acid involved in nitrogen metabolism, protein synthesis, nitric oxide production, and several metabolic pathways. It has also been used intravenously as a pharmacological stimulus in growth hormone (GH) stimulation testing. These physiological effects have led to widespread claims that oral arginine supplementation can increase linear growth in children and adolescents. However, an acute hormonal response should not be equated with a clinically meaningful increase in height. Evidence Acquisition: This narrative review examines the biological fate of arginine after administration and its relationship to GH secretion and growth plate physiology; it also examines evidence concerning insulin-like growth factor-1 (IGF-1) and clinical studies evaluating oral arginine supplementation and linear growth. Major pediatric and endocrine textbooks, international clinical guidelines, and recent systematic reviews and meta-analyses were considered, with particular attention to evidence directly evaluating growth outcomes rather than surrogate hormonal responses. Results: Arginine can acutely increase GH secretion, partly by attenuating somatostatin-mediated inhibition. However, this response is transient and differs substantially from sustained activation of the GH–IGF-1 axis and persistent stimulation of the growth plate. A 2023 systematic review and meta-analysis found no significant overall effect of arginine supplementation on IGF-1 concentrations. A 2026 systematic review and meta-analysis of oral arginine in prepubertal children with idiopathic short stature reported a small increase in height velocity in pooled analyses that included 6- or 12-month interventions, corresponding to a re-expressed mean difference of approximately 0.59 cm/year (95% CI: 0.19 – 1.00). However, the evidence was considered low quality, and the effect was not statistically significant when the analysis was restricted to 12-month interventions. Conclusions: Current evidence does not establish oral arginine as a standard treatment for increasing height in children and adolescents. The distinction between an acute GH response, a biological effect on the GH–IGF-1 axis, increased growth velocity, and an increase in adult height is essential when evaluating claims concerning arginine supplementation. In children with short stature, assessment of growth pattern, growth velocity, familial target height, pubertal status, nutritional status, and possible underlying disease should precede consideration of supplements. Further adequately powered randomized controlled trials with standardized growth outcomes and sufficiently long follow-up are needed.
  • Item type:Item,
    Targeting PD-1/PD-L1 in Advanced Thyroid Cancer: Therapeutic Efficacy, Predictive Biomarkers, and Clinical Challenges
    (Brieflands, 2026-09-30)
    Maziar Motiee-Langroudi
    ;
    Ebrahim Karimi
    ;
    Saeed Sohrabpour
    ;
    Keyvan Aghazadeh
    ;
    Farrokh Heidari
    Context: Thyroid cancer is the most common endocrine malignancy and generally has a favorable prognosis. However, aggressive subtypes and advanced radioactive iodine-refractory disease remain associated with limited therapeutic options and poor outcomes. The programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway has emerged as an important regulator of immune escape and a potential therapeutic target in advanced thyroid cancer. Evidence Acquisition: This narrative review examines evidence on PD-1/PD-L1 pathway biology, interactions between this pathway and the thyroid tumor immune microenvironment, molecular regulation, clinical significance, therapeutic applications, mechanisms of resistance, and future perspectives. Results: The PD-1/PD-L1 axis promotes immune evasion by suppressing T-cell activation, driving T-cell exhaustion, and establishing an immunosuppressive tumor microenvironment. PD-L1 expression is detectable across thyroid cancer subtypes, with the highest frequency reported in poorly differentiated and anaplastic carcinomas. The BRAF V600E mutation, mitogen-activated protein kinase pathway activation, PI3K/AKT signaling, inflammatory cytokines, and hypoxia contribute to PD-L1 regulation. Clinical responses to checkpoint blockade are heterogeneous, and the absence of validated predictive biomarkers remains a major obstacle. PD-L1 expression alone is insufficient for reliable patient selection. Conclusions: Targeting the PD-1/PD-L1 pathway offers therapeutic potential for selected patients with advanced thyroid cancer. Further progress requires integrated biomarker strategies that combine tumor genomics, immune profiling, and microenvironmental characteristics, as well as a better understanding of resistance mechanisms and validation in thyroid-specific clinical trials.
  • Item type:Item,
    Machine Learning-Based Prediction Models for Post-anesthesia Induction Hypotension: A Systematic Review and Meta-Analysis
    (Brieflands, 2026-08-31)
    Ali Dehghan Banadaki
    ;
    Sina Seydi
    ;
    Sana Mozaffari
    ;
    Erfan Soleymani
    ;
    Anita Fatehi
    Context: Post-induction hypotension (PIH), defined as a fall in arterial blood pressure between induction of general anesthesia and surgical incision, accounts for a substantial proportion of intraoperative hypotension and is associated with postoperative organ injury. Machine learning (ML) models have been proposed to identify patients at risk, but their performance, validation, and clinical readiness have not been appraised specifically for this prediction task. Evidence Acquisition: In this systematic review and meta-analysis, reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement, PubMed, Embase, Scopus, and Web of Science were searched from inception to 4 October 2025 for studies that developed or validated Machine learning (ML) models predicting PIH in adults under general anesthesia. Risk of bias was assessed with the Prediction model Risk Of Bias ASsessment Tool. For each study, we extracted the best-performing model and its most independent validation estimate. Areas under the receiver operating characteristic curve (area under the receiver operating characteristic curve (AUC)) were pooled on the logit scale with a restricted maximum-likelihood random-effects model, Hartung-Knapp-Sidik-Jonkman confidence intervals (CIs), and 95% prediction intervals, using one estimate per independent cohort. Sensitivity and specificity were pooled jointly with a bivariate random-effects model. Results: Ten reports (eight independent cohorts; 238,123 participants across reports, including overlapping samples) were included. No model had undergone geographic external validation, and calibration was reported for three models. The pooled AUC was 0.78 (95% CI 0.70 - 0.84; k = 8), with marked between-study heterogeneity (I2 = 97.7%) and a 95% prediction interval of 0.52 - 0.92. The summary sensitivity and specificity were 0.72 (95% CI 0.67 - 0.77) and 0.76 (95% CI 0.68 - 0.82), respectively (k = 6). Estimates were similar across sensitivity analyses, but the pooled AUC fell to 0.74 (95% CI 0.65 - 0.81) when the median-performing, rather than best-performing, model from each study was analyzed. Model families did not differ significantly (P = 0.59). Nine of the ten reports were at high overall risk of bias.
  • Item type:Item,
    Attachment Styles and Problematic Social Media Use in Adolescents: The Mediating Roles of Shame, Guilt, and Self-control
    (Brieflands, 2026-12-31)
    Zahra Heidari
    ;
    Amir Sam Kianimoghadam
    ;
    Farzin Bagheri Sheykhangafshe
    ;
    Fatemeh Khajeh HasaniRabari
    ;
    Ameneh Javanbakht
    Background: Adolescence is a distinct developmental period characterized by major biological, psychological, and social changes that heighten vulnerability to behavioral addictions, including problematic social media use (PSMU). The processes underlying the association between attachment styles and PSMU remain insufficiently understood. Objectives: This study aimed to examine the mediating roles of shame, guilt, and self-control (SC) in the relationship between attachment styles and PSMU among high-risk adolescents. Methods: In this cross-sectional study, 1,090 adolescents aged 12 - 17 years in Tehran, Iran, were recruited through convenience sampling and screened using the Bergen Social Media Addiction Scale; 547 adolescents who met the established cutoff (≥19) were included. Standardized measures of AS, shame, guilt, SC, and PSMU were administered. Path analysis based on structural equation modeling was conducted using SPSS 24 and AMOS 22 to assess direct and indirect pathways. Results: Attachment styles showed no significant direct effects on PSMU. However, preoccupied attachment had a significant indirect effect through guilt (B = 0.007, 95% confidence interval (CI) [0.001, 0.019], P = 0.015). Guilt had a negative direct association with PSMU (β = -0.134, P = 0.002), whereas shame had no significant direct effect (β = 0.072, P = 0.090). Serial mediation through shame and SC was significant for secure (B = -0.001, 95% CI [-0.003, 0], P = 0.047), fearful (B = -0.001, 95% CI [-0.002, 0], P = 0.041), and preoccupied attachment styles (B = 0.001, 95% CI [0, 0.003], P = 0.038). Conclusions: The findings suggest that associations between AS and PSMU operate partly through self-conscious emotions and self-regulatory processes, particularly guilt and SC. Prospective research in broader samples is warranted to clarify the temporal sequencing and stability of these associations. From a practical perspective, these findings may provide a preliminary basis for future research on how attachment patterns, self-conscious emotions, and self-regulatory capacities may inform the assessment and prevention of PSMU.
  • Item type:Item,
    Efficacy of Existential Group Therapy and Self-Compassion Therapy in Reducing Negative Perfectionism and Self-criticism Among Individuals with Obsessive-Compulsive Personality Disorder
    (Brieflands, 2026-12-31)
    Saba Moeinaddini
    ;
    Hamid Mollayi Zarandi
    ;
    Alireza Manzari Tavakoli
    ;
    Saba Moeinaddini [0000-0002-5258-0882]
    ;
    Hamid Mollayi Zarandi [0000-0002-6828-2177]
    Background: Maladaptive (negative) perfectionism and self-criticism are core therapeutic targets in obsessive-compulsive personality disorder (OCPD). Objectives: This study compared the efficacy of existential group therapy (EGT) and self-compassion therapy (SCT) in reducing negative perfectionism and self-criticism among individuals with OCPD. Methods: This quasi-experimental study used a pretest-posttest control group design with a 3-month follow-up. Forty-five adults diagnosed with OCPD in Kerman, Iran, during 2024 - 2025 were selected through purposive sampling and randomly allocated to three groups (n = 15 each): EGT (10 sessions of 90 minutes), SCT (10 sessions of 90 minutes), or a nonintervention control group. Outcomes were assessed using the Negative Perfectionism subscale of the Positive and Negative Perfectionism Scale and the Levels of Self-Criticism Scale. Data were analyzed using repeated-measures analysis of variance (ANOVA) with Bonferroni post hoc tests in SPSS version 26. Results: Both interventions significantly reduced negative perfectionism and self-criticism compared with the control group (P < 0.01 for all posttest comparisons). EGT was more effective than SCT in reducing negative perfectionism (P = 0.002). No significant difference was observed between EGT and SCT in reducing self-criticism, indicating comparable therapeutic efficacy. Conclusions: Both modalities reduced core OCPD symptoms. EGT provided greater clinical benefit for negative perfectionism, whereas EGT and SCT showed comparable efficacy in alleviating self-criticism.